Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
CLOSE
X
HOME CAPABILITIES Why Single Cell SNV SNV + CNV DNA + Protein Applications Oncology Research Multiple Myeloma AML MRD Precision Medicine Genome Editing Genome Integrity Assay Biomarker Development Cell and Gene Therapy Products & Services Tapestri Platform Panels Pharma Assay Development PAD for Cell & Gene Therapy PAD for Drug Development
RESOURCES BLOG PODCAST COMPANY About Us Careers Newsroom Events Distributors & Service Providers SUPPORT CENTER CONTACT PORTAL
X
Home Events Resolving tumor heterogeneity with single-cell co-detection of SNVs, CNVs &…
Events

Resolving tumor heterogeneity with single-cell co-detection of SNVs, CNVs & immunophenotypes

Virtual
Zoom Meeting
April 14, 2020
Register

 

Genotype and Phenotype

 

Resolving tumor heterogeneity with single-cell co-detection of SNVs, CNVs & immunophenotypes

April 14th, 2020

A Virtual Event- Live Zoom Webinar

 

 

 

SESSION
Resolving tumor heterogeneity with single-cell co-detection of SNVs, CNVs & immunophenotypes
DATE & TIME
04.14.2020
9:30AM
LOCATION
Zoom Meeting
PRESENTERS
Aaron Llanso, Associate Director of Market Development
ABSTRACT
Single-cell sequencing methods have enabled multi-modal characterization of tumor heterogeneity, and yielded novel insights into tumor evolution, therapeutic response & resistance, and measurable residual disease (MRD). Join us for an overview of the Tapestri Platform, and the novel capability to co-detect SNVs, CNVs, and immunophenotype from the same cell with a single, high-throughput workflow.
SESSION
Resolving tumor heterogeneity with single-cell co-detection of SNVs, CNVs & immunophenotypes.
DATE & TIME
04.14.2020
5:30PM
LOCATION
Zoom Meeting
PRESENTERS
Aaron Llanso, Associate Director of Market Development
ABSTRACT
Single-cell sequencing methods have enabled multi-modal characterization of tumor heterogeneity, and yielded novel insights into tumor evolution, therapeutic response & resistance, and measurable residual disease (MRD). Join us for an overview of the Tapestri Platform, and the novel capability to co-detect SNVs, CNVs, and immunophenotype from the same cell with a single, high-throughput workflow.

SIGN UP FOR PRODUCT AND EVENT UPDATES
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
CAPABILITIES
Why Single Cell SNV SNV + CNV DNA + Protein
APPLICATIONS
Oncology Research Multiple Myeloma AML MRD Precision Medicine Genome Editing Biomarker Development Cell and Gene Therapy
PRODUCTS & SERVICES
Tapestri Platform Panels Pharma Assay Development PAD for Cell & Gene Therapy PAD for Drug Development
COMPANY CAREERS NEWSROOM EVENTS BLOG RESOURCES SUPPORT CENTER CONTACT Terms of Use Privacy Policy Terms and Conditions of Sale Client Data Security & Retention
REQUEST QUOTE